This week, 10 Health Care Equipment & Supplies stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).
DexCom, Inc. (DXCM) experiences a ratings drop this week, going from last week’s B to a D. DexCom, Inc. is a medical device company focused on the design and development of continuous glucose monitoring systems for people with diabetes. The company also gets F’s in earnings revisions, earnings surprise, and return on equity. For more information, get Portfolio Grader’s complete analysis of DXCM stock.
Natus Medical Incorporated (BABY) slips from a C to a D this week. Natus Medical Incorporated is a medical device company that develops, manufactures, and markets screening products. For more information, get Portfolio Grader’s complete analysis of BABY stock.
This week, iRadimed Corp (IRMD) drops from a C to a D rating. The company also gets F’s in earnings momentum. For more information, get Portfolio Grader’s complete analysis of IRMD stock.
Rockwell Medical, Inc. (RMTI) declines this week from a C to a D. Rockwell Medical, Inc. manufactures, markets, and delivers dialysis solutions, powders, and ancillary products to hemodialysis providers. The company also gets F’s in earnings surprise and return on equity. For more information, get Portfolio Grader’s complete analysis of RMTI stock.
CytoSorbents Corporation’s (CTSO) rating weakens this week, dropping to a D versus last week’s C. The company also gets F’s in earnings surprise and return on equity. For more information, get Portfolio Grader’s complete analysis of CTSO stock.
ViewRay, Inc. (VRAY) gets weaker ratings this week as last week’s B drops to a D. The company also gets F’s in earnings surprise and free cash flow. For more information, get Portfolio Grader’s complete analysis of VRAY stock.
Slipping from a C to a D rating, CryoPort, Inc. (CYRX) takes a hit this week. The company also gets F’s in return on equity and free cash flow. For more information, get Portfolio Grader’s complete analysis of CYRX stock.
This is a rough week for Medigus Ltd Sponsored ADR (MDGS). The company’s rating falls to D from the previous week’s B. The company also gets F’s in return on equity. For more information, get Portfolio Grader’s complete analysis of MDGS stock.
Bellerophon Therapeutics, Inc. (BLPH) is having a tough week. The company’s rating falls from a C to a D. The company also gets F’s in return on equity and free cash flow. For more information, get Portfolio Grader’s complete analysis of BLPH stock.
Xtant Medical Holdings, Inc. (XTNT) earns a F this week, moving down from last week’s grade of D. The company also gets F’s in earnings revisions and free cash flow. For more information, get Portfolio Grader’s complete analysis of XTNT stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.
